Company Profile
biote Corp Stock Price, News & Analysis
- Ticker:
- BTMD
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
1.63 USD (-27.88%)
Close
Last updated: August 6, 2026
65.2M USD
Market cap
Why the stock is moving
Following the latest company update, “Biote Reports Second Quarter 2026 Financial Results”, BTMD closed down 27.9% at $1.63 on Aug 6, 2026. The move occurred in the trading session associated with this earnings update.
Company overview
Hormone Optimization
Biote operates a practitioner-led platform focused on hormone optimization and healthy aging. Its principal offering uses bioidentical hormone pellets implanted during office-based procedures.
Practitioner Network
The company trains and certifies medical practitioners, supplies procedure products and supports clinics with patient education, marketing and practice-management resources.
Wellness Products
Biote also sells dietary supplements and related wellness products through its practitioner network, extending the relationship beyond hormone-pellet procedures.
Future catalysts
biote’s catalysts are clinic-network growth, patient retention, and whether its hormone-optimization platform keeps scaling into a more durable cash-generating business. The next update that matters is the one that shows the consumer-health model is still gaining traction.
Recent news
- 01
Biote Reports Second Quarter 2026 Financial Results
Source: biote Corp
- 02
- 03
Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer
Source: biote Corp
- 04
- 05
Biote Reports First Quarter 2026 Financial Results
Source: biote Corp
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of biote Corp (BTMD)?
biote Corp (BTMD) most recently closed at 1.63 USD, a -27.88% move versus the previous session.
What is the market cap of biote Corp (BTMD)?
biote Corp currently has a market capitalization of 65.2M USD on BioPharmSignal.
What does biote Corp do?
Hormone Optimization Biote operates a practitioner-led platform focused on hormone optimization and healthy aging. Its principal offering uses bioidentical hormone pellets implanted during office-based procedures. Practitioner Network The company trains and certifies medical practitioners, supplies procedure products and supports clinics with patient...
On which exchange is BTMD stock listed?
biote Corp (BTMD) is associated with NASDAQ, United States, Biopharma.
What is Hormone?
biote’s catalysts are clinic-network growth, patient retention, and whether its hormone-optimization platform keeps scaling into a more durable cash-generating business.
Which conditions is biote Corp targeting with Hormone?
biote’s catalysts are clinic-network growth, patient retention, and whether its hormone-optimization platform keeps scaling into a more durable cash-generating business.
How does biote Corp describe recent progress with Hormone?
biote’s catalysts are clinic-network growth, patient retention, and whether its hormone-optimization platform keeps scaling into a more durable cash-generating business.
What is Optimization?
Hormone Optimization Biote operates a practitioner-led platform focused on hormone optimization and healthy aging.